NURS FPX 6212 Assessment 3: Outcome Measures, Issues, and Opportunities

Capella 6212 Assessment 3

NURS FPX 6212 Assessment 3: Outcome Measures, Issues, and Opportunities

Student Name

Capella University

School of Nursing and Health Sciences, Capella University

NURS-FPX 6212 Assessment 3:

Health Care Quality and Safety Management

Prof. Name:

Date

Outcome Measures, Issues, and Opportunities: Enhancing Medication Safety

Introduction: 

This comprehensive report aims to analyze outcome measures, issues, and opportunities pertinent to medication safety within our healthcare organization. Following the executive summary, this report delves into the complexities of medication errors and their implications for patient outcomes. The objective is to propose a comprehensive strategy to address these issues and to elevate patient care through systematic changes and enhanced measurement practices.

Analyzing Organizational Functions, Processes, and Behaviors: 

Critical functions, processes, and behaviors in high-performing healthcare organizations align to drive quality and safety. Such organizations manifest robust medication administration protocols, ongoing staff education, efficient communication practices, and a culture of transparency and accountability (Cardiff et al., 2020; Säfholm et al., 2019). These components act as cornerstones in reducing medication errors and nurturing a safety culture. Capella 6212 Assessment 3.

Impact of Organizational Functions on Outcome Measures: 

The identified organizational functions and behaviours wield a profound impact on outcome measures linked to medication safety. Robust medication administration protocols and continuous staff education directly contribute to diminished medication error rates and reduced adverse drug events (Fracica & Fracica, 2021; Schutijser et al., 2019). Transparent communication and accountability foster an environment where errors are promptly reported, facilitating timely interventions to mitigate harm NURS FPX 6212 Assessment 3: Outcome Measures, Issues, and Opportunities. (Cardiff et al., 2020; Walker et al., 2022). Consequently, these functions play a pivotal role in improving patient outcomes.

Quality and Safety Outcomes and Associated Measures: 

Quality and safety outcomes tied to medication safety encompass a broad spectrum, ranging from decreased adverse drug events and patient harm to elevated patient satisfaction, reduced healthcare-associated infections, and optimized resource utilization (Skelly et al., 2022; Walker et al., 2022). These outcomes are quantified through various measures, including ADE rates, medication error rates, infection rates, patient satisfaction scores, and length of hospital stays. Please refer to the appendix for an exhaustive spreadsheet detailing these measures.

Performance Issues and Opportunities: 

Multiple performance issues and opportunities demand attention to augment medication safety. Communication breakdowns among interdisciplinary teams, insufficient staff training, and the absence of standardized protocols for high-alert medications stand out as critical issues contributing to medication errors (Säfholm et al., 2019; Fracica & Fracica, 2021). Addressing these challenges through targeted interventions and process enhancements presents unique opportunities to enhance medication safety.

Strategy for Ensuring Comprehensive Measurement and Knowledge Sharing:

To ensure comprehensive measurement of patient care and widespread knowledge sharing among staff, the Plan-Do-Study-Act (PDSA) change model will be employed. The model unfolds as follows:

• Plan: Develop standardized medication administration protocols, enhance staff training, and establish interdisciplinary communication guidelines.
• Do: Implement proposed changes on a pilot basis within a select unit to gauge effectiveness and identify potential hurdles.
• Study: Analyze outcomes of pilot implementation, encompassing changes in medication error rates, ADE rates, and staff perceptions.
• Act: Based on findings, refine protocols and interventions, progressively scaling up implementation across the organization.

Conclusion: 

This report underscores the pivotal role of organizational functions, processes, and behaviors in shaping medication safety outcomes. By addressing performance issues through focused interventions and adopting the PDSA change model, we can optimize medication safety, bolster patient outcomes, and cultivate a culture steeped in safety within our organization. NURS FPX 6212 Assessment 3: Outcome Measures, Issues, and Opportunities. We can carve a path towards a safer and higher-quality healthcare environment through an unwavering commitment to improvement and rigorous measurement practices.

References:

Cardiff, S., Sanders, K., Webster, J., & Manley, K. (2020). Guiding lights for effective workplace cultures that are also good places to work. International Practice Development Journal, 10(2). https://doi.org/10.19043/ipdj.102.002v2  

Capella 6212 Assessment 3

Cardwell, K., Smith, S. M., Clyne, B., McCullagh, L., Wallace, E., Kirke, C., & Moriarty, F. (2020). Evaluation of the General Practice Pharmacist (GPP) intervention to optimize prescribing in Irish primary care: A non-randomized pilot study. BMJ open, 10(6), e035087.  https://doi.org/10.1136/bmjopen-2019-035087 

Fracica, P. J., & Fracica, E. A. (2021). Patient safety. Medical Quality Management: Theory and Practice, 53-90. https://doi.org/10.1007/978-3-030-48080-6_4 

Kangasniemi, M., Karki, S., Colley, N., & Voutilainen, A. (2019). The use of robots and other automated devices in nurses’ work: An integrative review. International Journal of Nursing Practice, 25(4), e12739.  https://doi.org/10.1111/ijn.12739 

NURS FPX 6212 Assessment 3: Outcome Measures, Issues, and Opportunities

Kaplan, B. (2020). Revisiting health information technology ethical, legal, and social issues and evaluation: telehealth/telemedicine and COVID-19. International journal of medical informatics, 143, 104239.  https://doi.org/10.1016/j.ijmedinf.2020.104239  

Capella 6212 Assessment 3

Moore, W., & Frye, S. (2019). Review of HIPAA, Part 1: History, protected health information, and privacy and security rules. Journal of nuclear medicine technology, 47(4), 269-272.  https://doi.org/10.2967/jnmt.119.227819 

Nana-Sinkam, P., Kraschnewski, J., Sacco, R., Chavez, J., Fouad, M., Gal, T., … & Behar-Zusman, V. (2021). Health disparities and equity in the era of COVID-19. Journal of Clinical and Translational Science, 5(1), e99. https://doi.org/10.1017/cts.2021.23 

Säfholm, S., Bondesson, Å., & Modig, S. (2019). Medication errors in primary health care records: A cross-sectional study in Southern Sweden. BMC Family Practice, 20, 1-7. https://doi.org/10.1186/s12875-019-1001-0 

NURS FPX 6212 Assessment 3: Outcome Measures, Issues, and Opportunities

Schutijser, B. C. F. M., Jongerden, I. P., Klopotowska, J. E., Portegijs, S., de Bruijne, M. C., & Wagner, C. (2019). Double checking injectable medication administration: Does the protocol fit clinical practice?. Safety Science, 118, 853-860.  https://doi.org/10.1016/j.ssci.2019.06.026 

Skelly, C. L., Cassagnol, M., & Munakomi, S. (2022). Adverse events. In StatPearls [Internet]. StatPearls Publishing.https://www.ncbi.nlm.nih.gov/books/NBK558963/ 

Smith, A. F., & Plunkett, E. (2019). People, systems and safety: Resilience and excellence in healthcare practice. Anaesthesia, 74(4), 508-517.  https://doi.org/10.1111/anae.14519 

Walker, M., Hutchison, J., Lesak, D., Calvo, L., Friese, J., Garza, C., & Budin, L. (2022). Decreasing medication errors at discharge: A quality improvement project. Pediatrics, 149(1 Meeting Abstracts February 2022), 145-145.  https://doi.org/10.1097/pq9.0000000000000599